Exagen Inc., founded with a mission to improve the diagnosis and monitoring of autoimmune rheumatic diseases, is a commercial-stage diagnostics company. The company offers a range of diagnostic tests designed to address the specific needs of patients suffering from these conditions. Exagen’s core vision is to enhance patient care through innovative diagnostic solutions, providing critical insights for both physicians and patients. Their products and services are utilized globally, reflecting their commitment to advancing healthcare in the autoimmune sector.

Notable affiliated individuals include key medical professionals and researchers who contribute to the development of Exagen’s diagnostic tools. The company has attracted significant investment from prominent healthcare-focused venture capital firms. Among its key achievements, Exagen has successfully developed and commercialized several diagnostic tests that have become integral in the management of autoimmune diseases. The overall impact of Exagen’s work is evident in improved patient outcomes and enhanced disease monitoring, solidifying its position as a leader in the diagnostics industry.